MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral genome engineering system, supporting the development and manufacture of immune cell- and stem cell-based therapies. The TcBuster System has been widely used by researchers to introduce large […]
Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc. Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the appointment of William J. Kullback to its Board of Directors as a Non-Executive Director (NED). Bill is […]
SAN DIEGO, CALIFORNIA — Rancho BioSciences, the premier tech-enabled data science partner for biopharma, welcomes Bristol Myers Squibb (BMS) back for the 2nd phase of The Single-Cell Data Science Consortium. This continuing initiative aims to build on Phase 1’s foundation, bringing together leading pharmaceutical companies with shared goals and needs in the realm of single-cell data. […]
Today, BC Platforms (BCP), a global leader in real-world data (RWD), healthcare data management, and analytics, announces the appointment of Mukhtar Ahmed as its new Chief Executive Officer, effective February 17th, 2025. Over his 30-year career, Mukhtar has served on the boards of the National Health Service (NHS) and several venture capital and private equity-funded companies. He was […]
São Paulo – MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, established a partnership with Oncoclínicas&Co, through OC Medicina de Precisão, which comprises Genomics, Pathology and Big Data laboratories, to expand access to cutting-edge genomic tests and strengthen diagnostic capabilities in the field of […]
Transaction To Complement Bio-Rad’s Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to purchase all equity interests in Stilla […]
Family business invests in start-up Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor, so the two companies can work together to develop more efficient, flexible, and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more cost-effective production of therapeutics and facilitate […]
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of autoimmune diseases ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, […]
The Invitrogen™ EVOS™ S1000 Spatial Imaging System features intuitive software that empowers researchers to achieve more with their tissue samples while reducing sample processing time. WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses the limitations of current […]
Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
